Avidity Biosciences Inc
NASDAQ:RNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avidity Biosciences Inc
NASDAQ:RNA
|
US |
|
Deutsche Post AG
XETRA:DHL
|
DE |
|
Seven West Media Ltd
ASX:SWM
|
AU |
|
E
|
EVN AG
VSE:EVN
|
AT |
|
Arcosa Inc
NYSE:ACA
|
US |
|
Culp Inc
NYSE:CULP
|
US |
|
R
|
Rural Funds Group
ASX:RFF
|
AU |
|
Restaurant Brands International Inc
NYSE:QSR
|
CA |
|
Valneva SE
PAR:VLA
|
FR |
|
I
|
Intesa Sanpaolo SpA
BMV:ISPN
|
IT |
|
Peab AB
F:PEKB
|
SE |
Wall St Price Targets
RNA Price Targets Summary
Avidity Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
RNA is 25.5 USD with a low forecast of 25.25 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RNA's stock price target?
Price Target
25.5
USD
According to Wall Street analysts, the average 1-year price target for
RNA is 25.5 USD with a low forecast of 25.25 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Avidity Biosciences Inc?
Projected CAGR
-34%
Over the last 1 year, the compound annual growth rate for Revenue has been 71%. The projected CAGR for the next 2 years is -34%.